John A. Abraham, MD, FACS, discusses surgical improvements in tenosynovial giant cell tumor.
John A. Abraham, MD, FACS
Advertisement
Articles by John A. Abraham, MD, FACS
John A. Abraham, MD, FACS, discusses remaining questions with pexidartinib in tenosynovial giant cell tumor.
John A. Abraham, MD, FACS, discusses the clinical utility of pexidartinib in tenosynovial giant cell tumor.
John A. Abraham, MD, FACS, discusses the surgical management of patients with tenosynovial giant cell tumor.
John A. Abraham, MD, FACS, discusses future research efforts in tenosynovial giant cell tumor.
John A. Abraham, MD, FACS, discusses key considerations regarding the management of tenosynovial giant cell tumor.
John A. Abraham, MD, FACS, discusses potential symptoms of tenosynovial giant cell tumor.
Advertisement
Latest Updated Articles
Dr. Abraham on Surgical Improvements in TGCTNovember 5th 2020
Dr. Abraham on Remaining Questions With Pexidartinib in TGCTOctober 21st 2020
Dr. Abraham on the Surgical Management of TGCTOctober 2nd 2020
Dr. Abraham on Potential Symptoms of TGCTApril 29th 2020
Dr. Abraham on the Clinical Utility of Pexidartinib in TGCTOctober 20th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
3
The OncFive: Top Oncology Articles for the Week of 5/31
4
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
5